127 related articles for article (PubMed ID: 1653364)
1. Effect of recombinant fibroblast interferon and recombinant immune interferon on growth and the antigenic phenotype of multidrug-resistant human glioblastoma multiforme cells.
Reddy PG; Graham GM; Datta S; Guarini L; Moulton TA; Jiang HP; Gottesman MM; Ferrone S; Fisher PB
J Natl Cancer Inst; 1991 Sep; 83(18):1307-15. PubMed ID: 1653364
[TBL] [Abstract][Full Text] [Related]
2. Induction of growth suppression and modification of gene expression in multi-drug-resistant human glioblastoma multiforme cells by recombinant human fibroblast and immune interferon.
Moulton TA; Jiang H; Guarini L; Fetell MR; Fisher PB
Int J Cancer; 1992 May; 51(3):373-8. PubMed ID: 1317362
[TBL] [Abstract][Full Text] [Related]
3. Fludarabine phosphate selectively inhibits growth and modifies the antigenic phenotype of human glioblastoma-multiforme cells expressing a multidrug resistance phenotype.
Jiang H; Su Z; Datta S; Guarini L; Waxman S; Fisher P
Int J Oncol; 1992 Jul; 1(2):227-39. PubMed ID: 21584536
[TBL] [Abstract][Full Text] [Related]
4. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons.
Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB
Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M
Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferons.
Graham GM; Guarini L; Moulton TA; Datta S; Ferrone S; Giacomini P; Kerbel RS; Fisher PB
Cancer Immunol Immunother; 1991; 32(6):382-90. PubMed ID: 1672507
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the antigenic phenotype of human breast carcinoma cells by modifiers of protein kinase C activity and recombinant human interferons.
Leon JA; Gutierrez MC; Jiang H; Estabrook A; Waxman S; Fisher PB
Cancer Immunol Immunother; 1992; 35(5):315-24. PubMed ID: 1356626
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the antigenic phenotype of early-passage human melanoma cells derived from multiple autologous metastases by recombinant human leukocyte, fibroblast and immune interferon.
Giacomini P; Fraioli R; Nistico P; Tecce R; Nicotra MR; Di Filippo F; Fisher PB; Natali PG
Int J Cancer; 1990 Sep; 46(3):539-45. PubMed ID: 2118485
[TBL] [Abstract][Full Text] [Related]
9. Expression and modulation by cytokines of the intercellular adhesion molecule-1 (ICAM-1) in human central nervous system tumor cell cultures.
Guarini L; Temponi M; Bruce JN; Bollon AP; Duigou GJ; Moulton TA; Ferrone S; Fisher PB
Int J Cancer; 1990 Dec; 46(6):1041-7. PubMed ID: 1979069
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
Ziai MR; Imberti L; Tongson A; Ferrone S
Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
[TBL] [Abstract][Full Text] [Related]
11. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of interferon-gamma-induced class II expression on human glioma cells by recombinant interferon-beta: effects of dosage treatment schedule.
Joseph J; Knobler RL; D'Imperio C; Lublin FD
J Neuroimmunol; 1988 Nov; 20(1):39-44. PubMed ID: 2846654
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing agents.
Guarini L; Graham GM; Jiang H; Ferrone S; Zucker S; Fisher PB
Pigment Cell Res; 1992; Suppl 2():123-31. PubMed ID: 1357650
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
[TBL] [Abstract][Full Text] [Related]
15. Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme.
Yang I; Kremen TJ; Giovannone AJ; Paik E; Odesa SK; Prins RM; Liau LM
J Neurosurg; 2004 Feb; 100(2):310-9. PubMed ID: 15086239
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype.
Garbe C; Krasagakis K; Zouboulis CC; Schröder K; Krüger S; Stadler R; Orfanos CE
J Invest Dermatol; 1990 Dec; 95(6 Suppl):231S-237S. PubMed ID: 2124247
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon gamma.
Anichini A; Mortarini R; Fossati G; Parmiani G
Int J Cancer; 1986 Oct; 38(4):505-11. PubMed ID: 3093392
[TBL] [Abstract][Full Text] [Related]
20. Identification of an interferon-gamma response region 5' of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines.
Basta PV; Sherman PA; Ting JP
J Immunol; 1987 Feb; 138(4):1275-80. PubMed ID: 3027177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
